Spain Nuclear Imaging Market Size, Share, and COVID-19 Impact Analysis, By Product (SPECT Imaging Systems, PET Imaging Systems, and Planar Scintigraphy Imaging Systems), By Application (Oncology, Cardiology, Neurology, and Others), and Spain Nuclear Imaging Market Insights, Industry Trend, Forecasts to 2033

Spain Nuclear Imaging Market Insights Forecasts to 2033

• The Spain Nuclear Imaging Market Size Was Valued at USD 160.5 Million in 2023.
• The Spain Nuclear Imaging Market Size is Growing at a CAGR of 2.65% From 2023 to 2033
• The Spain Nuclear Imaging Market Size is Expected to reach USD 208.5 Million By 2033

The Spain Nuclear Imaging Market Size is Anticipated to Exceed USD 208.5 Million By 2033, Growing at a CAGR of 2.65% From 2023 to 2033. The Growing prevalence of chronic diseases, rising geriatric population, and increasing technological advancements are driving the growth of the nuclear imaging market in the Spain.     

Market Overview

The nuclear imaging market refers to the segment of the medical imaging industry that uses radioactive tracers and specialized equipment to visualize and assess the physiological and metabolic functions of organs and tissues. Nuclear imaging produces images by detecting radiation from different parts of the body after a radioactive tracer material is administered and is recorded on a computer and on film. It can be used to treat conditions or to evaluate treatment working. There is major surge of the medical imaging industry in diagnostics and treatment due to increased patients’ hospital visits for imaging diagnosis along with the increased incidences of chronic diseases. The rising need for the data integrated imaging systems owing to their advantages and convenience for clinicians are offering market growth opportunities for nuclear imaging.

Report Coverage

This research report categorizes the market for the Spain nuclear imaging market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Spain nuclear imaging market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Spain nuclear imaging market.

Driving Factors

The growing prevalence of chronic diseases such as hypertension which is estimated to be found in 19.34% of the Spanish population contributes to driving market demand for nuclear imaging for diagnosis which provides functional and molecular information about the body. The rising geriatric population along with the increased number of older people living in Spain’s nursing homes are likely to drive the market demand. The technological advancements in nuclear imaging including the development of more sophisticated detectors, improved imaging systems like PET and SPECT combined with CT and MRI, and advanced image reconstruction and analysis methods propelling the market growth.

Restraining Factors

The lack of reimbursement policies and strict regulatory approval procedures are hindering the market. In addition, the increased equipment price limits its adoption, thereby hampering the market growth.

Market Segmentation

The Spain nuclear imaging market share is classified into product and application.

• The SPECT imaging systems segment dominated the market with the largest revenue share in 2023 and is anticipated to grow at a significant CAGR growth during the projected period.

The Spain nuclear imaging market is segmented by product into SPECT imaging systems, PET imaging systems, and planar scintigraphy imaging systems. Among these, the SPECT imaging systems segment dominated the market with the largest revenue share in 2023 and is anticipated to grow at a significant CAGR growth during the projected period. The widespread use of SPECT imaging systems for disease evaluation and the prevalence of breast cancer and prostate cancer are anticipated to propel the market.

• The oncology segment dominated the market with the largest market share in 2023 and is anticipated to grow at a significant CAGR growth during the forecast period.

The Spain nuclear imaging market is segmented by application into oncology, cardiology, neurology, and others. Among these, the oncology segment dominated the market with the largest market share in 2023 and is anticipated to grow at a significant CAGR growth during the forecast period. Nuclear imaging is used in oncology for diagnosing, staging, monitoring treatment response, and treatment by using techniques like PET scans and radionuclide therapies.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Spain nuclear imaging market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Curium
• Bayer AG
• Bracco Group
• Novartis AG (Advanced Accelerator Applications)
• Fujifilm Holdings Corporation
• Canon Inc. (Canon Medical Systems Corporation)
• Carestream health
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• GE Healthcare
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In August 2022, the Nuclear Medicine-PET Service at Bellvitge University Hospital, Spain incorporated a digital SPECT-CT gamma camera. This new device would allow progress in care and research in the field of oncology.

• In July 2021, Quibim, a global leader in artificial intelligence (AI) and medical image processing, is participating in a €7.5M (US$8.9M) High Sensitivity Molecular Imaging project IMAS (Imagen Molecular de Alta Sensibilidad) to build an innovative total-body PET/CT scanner for simultaneous whole-body imaging in a Temporary Business Association (TBA) backed by world-class experts in diagnostic imaging equipment GE Healthcare.

Market Segment

This study forecasts revenue at Spain, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Spain nuclear imaging market based on the below-mentioned segments:

Spain Nuclear Imaging Market, By Product

• SPECT Imaging Systems
• PET Imaging Systems
• Planar Scintigraphy Imaging Systems

Spain Nuclear Imaging Market, By Application  

• Oncology
• Cardiology
• Neurology
• Others